Skip to Content

Surmodics Inc SRDX Stock Quote

| Rating as of

Morningstar‘s Stock Analysis SRDX

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics SRDX

Company Profile SRDX

Business Description

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using our technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit and the Vitro diagnostics unit. Surmodics derives most of its revenue from the Vitro diagnostics segment.

9924 West 74th Street
Eden Prairie, MN, 55344
T +1 952 500-7000
Industry Medical Devices
Most Recent Earnings Jun 30, 2022
Fiscal Year End Sep 30, 2022
Stock Type Slow Growth
Employees 389